eyecooltx.com
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.eyecooltx.comRevenue
<$5 MillionIndustry
About eyecooltx.com
eyecooltx.com Org Chart
Is eyecooltx.com your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once eyecooltx.com has new funding data
Check out if eyecooltx.com is spiking on competitors!
Earning: See what the market has to say on eyecooltx.com recently announced quarterly report
Click to see if eyecooltx.com had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when eyecooltx.com launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if eyecooltx.com has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at eyecooltx.com
eyecooltx.com, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at eyecooltx.com
Find more new buyers
Company Profile Activity
Activity Insights
eyecooltx.com is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
eyecooltx.com is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about eyecooltx.com.
eyecooltx.com Tech Stack
A closer look at the technologies used by eyecooltx.com
Most Recent Scoops
eyecooltx.com News & Media
EyeCool Therapeutics Announces New ETX-4143 Data to Be Presented at ARVO 2026
Presentations add to growing evidence supporting safety and efficacy of this novel device in chronic ocular surface pain. BOSTON, MA, UNITED STATES, April 29, 2026 /EINPresswire.com/ -- EyeCool Therapeutics today announced that new data on its …EyeCool Therapeutics Announces Encouraging Interim Clinical Results for ETX-4143 in Chronic Ocular Surface Pain
BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic medical device company, today announced encouraging interim results from its ongoing ETX4143-A005 clinical study being conducted at the …
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding eyecooltx.com
EyeCool Therapeutics is dedicated to providing effective solutions for patients experiencing Chronic Ocular Surface Pain (COSP), a condition that currently lacks FDA-approved treatments. The company aims to address the significant unmet need for fast and lasting relief in this patient population, which includes millions of U.S. adults. Their focus... Read More